Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and cardiovascular toxicities

Immune checkpoint inhibitors (ICIs) have become a cornerstone of treatment for many solid organ malignancies. Alongside increasing use, the occurrence of immune-related adverse events (irAEs) has also increased and remains a significant challenge when treating patients with ICI. The underlying patho...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

J. McKenzie [verfasserIn]

E. Sneath [verfasserIn]

A. Trinh [verfasserIn]

M. Nolan [verfasserIn]

L. Spain [verfasserIn]

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2024

Schlagwörter:

immunotherapy

immune-related adverse events

enterocolitis

hepatitis

myocarditis

Übergeordnetes Werk:

In: Immuno-Oncology and Technology - Elsevier, 2021, 21(2024), Seite 100704-

Übergeordnetes Werk:

volume:21 ; year:2024 ; pages:100704-

Links:

Link aufrufen
Link aufrufen
Link aufrufen
Journal toc

DOI / URN:

10.1016/j.iotech.2024.100704

Katalog-ID:

DOAJ094753857

Nicht das Richtige dabei?

Schreiben Sie uns!